These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21797119)

  • 21. Surgical management and outcomes for stage 1 malignant ovarian germ cell tumours: A UK multicentre retrospective cohort study.
    Graham R; MacDonald ND; Lockley M; Miller R; Butler J; Murali K; Sarker SJ; Banerjee S; Stoneham S; Shamash J; Liberale V; Berney DM; Newton C
    Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():138-144. PubMed ID: 35192975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study.
    Mangili G; Giorda G; Ferrandina G; Cormio G; Cassani C; Savarese A; Danese S; Carnelli M; Vasta FM; Perrone AM; Scarfone G; Pignata S; Legge F; Raspagliesi F; Taccagni G; Candiani M; Bogani G; Mascilini F; Bergamini A
    Int J Gynecol Cancer; 2021 Sep; 31(9):1242-1247. PubMed ID: 34035080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of residual disease in advanced stage malignant ovarian germ cell tumors.
    Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K
    Int J Gynecol Cancer; 2019 Mar; 29(3):554-559. PubMed ID: 30700566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
    Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.
    Mangili G; Sigismondi C; Gadducci A; Cormio G; Scollo P; Tateo S; Ferrandina G; Greggi S; Candiani M; Lorusso D
    Int J Gynecol Cancer; 2011 Nov; 21(8):1414-21. PubMed ID: 21795985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant mixed ovarian germ cell tumor with embryonal component.
    Moniaga NC; Randall LM
    J Pediatr Adolesc Gynecol; 2011 Feb; 24(1):e1-3. PubMed ID: 20869284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of fertility preserving operations in malignant ovarian tumors].
    Kleine W
    Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fertility-sparing surgery for patients with malignant ovarian germ cell tumors: 10 years of clinical experience from a tertiary referral center.
    Mikuš M; Benco N; Matak L; Planinić P; Ćorić M; Lovrić H; Radošević V; Puževski T; Bajt M; Vujić G
    Arch Gynecol Obstet; 2020 May; 301(5):1227-1233. PubMed ID: 32253553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes and prognostic factors of patients with recurrent and persistent malignant ovarian germ cell tumors.
    Wang J; Zhuo X; Yang J; Cao D; Shen K; Huang H; Wu M; Pan L; Xiang Y; Guo L
    Arch Gynecol Obstet; 2020 Apr; 301(4):1021-1026. PubMed ID: 32198624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of conservative surgical practices for malignant ovarian germ cell tumors.
    Chan JK; Tewari KS; Waller S; Cheung MK; Shin JY; Osann K; Kapp DS
    J Surg Oncol; 2008 Aug; 98(2):111-6. PubMed ID: 18563734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immature teratoma of ovary--outcome following primary and secondary surgery: study of a single institution cohort.
    Reddihalli PV; Subbian A; Umadevi K; Rathod PS; Krishnappa S; Nanaiah SP; Bafna UD
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():17-21. PubMed ID: 26142911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2015 Jun; 137(3):418-22. PubMed ID: 25842162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical intervention strategies for pediatric ovarian tumors: experience with 60 cases at one institution.
    Tajiri T; Souzaki R; Kinoshita Y; Yosue R; Kohashi K; Oda Y; Taguchi T
    Pediatr Surg Int; 2012 Jan; 28(1):27-31. PubMed ID: 22089368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perinatal (fetal and neonatal) germ cell tumors.
    Isaacs H
    J Pediatr Surg; 2004 Jul; 39(7):1003-13. PubMed ID: 15213888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Multicenter randomized controlled clinical study for the operative treatment of malignant ovarian germ cell tumors].
    Liu Q; Ding XL; Yang JX; Cao DY; Shen K; Lang JH; Zhang GN; Xin XY; Xie X; Zhang SL; Wu YM; Zhu GH; Wang J; Chen YL; Kong BH; Zheng JH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Mar; 48(3):188-92. PubMed ID: 23849941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors.
    Ertas IE; Taskin S; Goklu R; Bilgin M; Goc G; Yildirim Y; Ortac F
    J Obstet Gynaecol Res; 2014 Mar; 40(3):797-805. PubMed ID: 24320102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary.
    Talukdar S; Kumar S; Bhatla N; Mathur S; Thulkar S; Kumar L
    Gynecol Oncol; 2014 Jan; 132(1):28-32. PubMed ID: 24145115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome and prognostic factors in ovarian germ cell malignancies.
    Lai CH; Chang TC; Hsueh S; Wu TI; Chao A; Chou HH; Wang PN
    Gynecol Oncol; 2005 Mar; 96(3):784-91. PubMed ID: 15721426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The malignant potential of teratomas in infancy and childhood: the MAKEI experiences in non-testicular teratoma and implications for a new protocol.
    Göbel U; Calaminus G; Schneider DT; Koch S; Teske C; Harms D
    Klin Padiatr; 2006; 218(6):309-14. PubMed ID: 17080332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.